|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-5-5
|
|
pubmed:abstractText |
The purpose of this study was to demonstrate a novel protein-based magnetic resonance imaging (MRI) contrast agent that has the capability of targeting prostate cancer and which provides high-sensitivity MR imaging in tumor cells and mouse models.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1860-2002
|
|
pubmed:author |
pubmed-author:CastiblancoAdrianaA,
pubmed-author:ChenYanyiY,
pubmed-author:HuXiaopingX,
pubmed-author:JohnsonJulianJ,
pubmed-author:LiShunyiS,
pubmed-author:LiuZhi-RenZR,
pubmed-author:LongRobertR,
pubmed-author:MaorNatalieN,
pubmed-author:OrrE CEC,
pubmed-author:QiaoJingjuanJ,
pubmed-author:WangLiyaL,
pubmed-author:WeiLixiaL,
pubmed-author:YangJenny JJJ,
pubmed-author:YangJianhuaJ,
pubmed-author:YeYimingY,
pubmed-author:ZhaoTiejunT,
pubmed-author:ZhouWangdaW,
pubmed-author:ZouJinJ,
pubmed-author:ZurkiyaOmarO
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
416-23
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Protein-based MRI contrast agents for molecular imaging of prostate cancer.
|
|
pubmed:affiliation |
Department of Chemistry and Biology, Georgia State University, Atlanta, GA 30302, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
